Does NIVOLUMAB Cause Hyperthermia? 79 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 79 reports of Hyperthermia have been filed in association with NIVOLUMAB (OPDIVO). This represents 0.1% of all adverse event reports for NIVOLUMAB.
79
Reports of Hyperthermia with NIVOLUMAB
0.1%
of all NIVOLUMAB reports
25
Deaths
64
Hospitalizations
How Dangerous Is Hyperthermia From NIVOLUMAB?
Of the 79 reports, 25 (31.6%) resulted in death, 64 (81.0%) required hospitalization, and 7 (8.9%) were considered life-threatening.
Is Hyperthermia Listed in the Official Label?
Yes, Hyperthermia is listed as a known adverse reaction in the official FDA drug label for NIVOLUMAB.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
What Other Drugs Cause Hyperthermia?
QUETIAPINE (265)
OLANZAPINE (210)
ACETAMINOPHEN (196)
OXALIPLATIN (195)
RISPERIDONE (166)
LAMOTRIGINE (156)
HALOPERIDOL (138)
CARBOPLATIN (129)
FLUOROURACIL (115)
SERTRALINE (109)
Which NIVOLUMAB Alternatives Have Lower Hyperthermia Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE